Pharmacotherapy for age-related behavioral... (1981 study) Skip to main content
Review The Journal of nervous and mental disease 1981

Pharmacotherapy for age-related behavioral deficiencies.

Wittenborn JR, The Journal of nervous and mental disease, 1981

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The author reviewed research on drugs used to treat behavior problems linked to aging, and separated them from drugs used for disturbed behavior in adults of all ages.

What They Found

This review found that placebo-controlled studies confirmed many responses to drugs designed to treat impaired behavior in old people. The abstract gives no numbers, sample sizes, or named drugs. It says normal or mildly impaired people also responded to some of these drugs. The author suggests this points to a possible preventive use.

What This Means for Canadian Patients

The abstract does not address hyperbaric oxygen therapy. It covers only drugs for age-related behavior loss, so it gives no information about HBOT for older adults. Anyone with questions about memory or behavior changes with age should talk with their own doctor.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract gives no details on how many studies were reviewed, which drugs or patients were involved, or how large the responses were, and the preventive use is described only as a possibility.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Systematic Reviews
Source Pubmed
PubMed ID 6110700
Year Published 1981
Journal The Journal of nervous and mental disease
MeSH Terms Adult; Aged; Aging; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Brain; Central Nervous System Stimulants; Cerebrovascular Disorders; Humans; Hyperbaric Oxygenation; Meclofenoxate; Mental Disorders; Middle Aged; Nicotinic Acids

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology